Dr. Vikalp earned his PhD in Salmonella vaccine development from the School of Biotechnology, KIIT University - Bhubaneswar, India. He completed his research in collaboration with ETH Zurich, Switzerland where he worked in the lab of Prof. Wolf Dietrich Hardt. His research interest includes identification of virulence factors and development of mucosal vaccine strains against enteric bacterial pathogens. As a postdoctoral researcher, he worked at Kansas University Medical Center, Kansas City KS for a year and moved to KU Lawrence as part of Kansas Vaccine Institute. At KU, he is working on in vivo screening and validation of recombinant subunit vaccines for Shigellosis and Salmonellosis.